<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01516333</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 26026</org_study_id>
    <nct_id>NCT01516333</nct_id>
  </id_info>
  <brief_title>Replace Glycemic Load and Satiety Study</brief_title>
  <official_title>Response of Energy Peak Levels After Carbohydrates Are Eaten Glycemic Load and Satiety Study - Phase 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>General Mills</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to examine the effect of four diets differing in glycemic index and amount of&#xD;
      carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The extent to which a food raises blood sugar after its consumption is ranked using the&#xD;
      Glycemic Index (GI). Foods with a high GI are those taht cause a large and rapid rise in&#xD;
      blood sugar while those with a low GI produce small fluctuations in blood sugar. It is&#xD;
      believed that low GI foods are advantageous for health since the swings in blood sugar and&#xD;
      insulin resistant or diabetic. Interestingly, some studies suggest that low GI food make you&#xD;
      less hungry and that this may play an important role in body weight regulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Glucose over time</measure>
    <time_frame>1 month</time_frame>
    <description>Blood glucose demonstrates that diets of different glycemic load result in measurable differences in serum glucose and insulin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog scores (VAS)</measure>
    <time_frame>1 month</time_frame>
    <description>Hunger, satiety, and vigor will be measured by the visual analog scales.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Glucose Blood</condition>
  <condition>Glycemic Index</condition>
  <arm_group>
    <arm_group_label>Diet 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High GI; High Carb; High GL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High GI, Low Carb, Med GL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low GI, High Carb, Med GL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low GI, Low Carb, Low GL</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High GL 107</intervention_name>
    <description>Three meals a day</description>
    <arm_group_label>Diet 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medium GL 76</intervention_name>
    <description>Three meals a day</description>
    <arm_group_label>Diet 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medium GL 68</intervention_name>
    <description>Three meals a day</description>
    <arm_group_label>Diet 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low GL 48</intervention_name>
    <description>Three meals a day</description>
    <arm_group_label>Diet 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body Mass index between 25-35 kg/m2&#xD;
&#xD;
          -  Fasting serum glucose&#xD;
&#xD;
          -  Fasting serum glucose &lt; 125 mg/dl&#xD;
&#xD;
          -  Free of chronic disease&#xD;
&#xD;
          -  Willing to eat only the foods that are provided by the Center during the diet periods&#xD;
&#xD;
          -  Willing to abstain from the consumption of alcohol during the diet periods&#xD;
&#xD;
          -  Regularly cycling and willing not to become pregnant using birth control (abstinence,&#xD;
             barrier methods, partner surgically sterile&#xD;
&#xD;
          -  Monophasic birth control (same dose each day)&#xD;
&#xD;
          -  Hormone replacement therapy&#xD;
&#xD;
          -  Post-menopausal (over 1 year without bleeding)&#xD;
&#xD;
          -  Have had partial hysterectomy over the age of 55&#xD;
&#xD;
          -  complete hysterectomy at any age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented presence of atherosclerotic disease&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Renal, hepatic, endocrine, gastrointestinal, hematological or other systemic disease&#xD;
&#xD;
          -  Body Mass Index &lt;25 or &gt; 35&#xD;
&#xD;
          -  History of drug or alcohol abuse in the last year&#xD;
&#xD;
          -  For women, pregnancy, breast feeding or postpartum &lt; 6 months&#xD;
&#xD;
          -  History of depression or mental illness requiring treatment or medication within that&#xD;
             last 6 months&#xD;
&#xD;
          -  Multiple food allergies or significant food preferences or restrictions that would&#xD;
             interfere with diet adherence&#xD;
&#xD;
          -  Lifestyle or schedule incompatible with the study protocol&#xD;
&#xD;
          -  Planned continued use of dietary supplements through the study trial&#xD;
&#xD;
          -  Smoking or tobacco use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank L Greenway, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Cefalu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Pennington Biomedial Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marlene M Most, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>January 19, 2012</study_first_submitted>
  <study_first_submitted_qc>January 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2012</study_first_posted>
  <last_update_submitted>December 17, 2015</last_update_submitted>
  <last_update_submitted_qc>December 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Frank Greenway</investigator_full_name>
    <investigator_title>Medial Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>glycemic Index</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

